AXQ Capital’s Phibro Animal Health PAHC Stock Holding History

AXQ Capital’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,645	Closed	-$227K	–	725
2025 Q1	$227K	Buy	+10,645	New	+$238K	0.09%	370

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AXQ Capital's PAHC Position: Q2 2025 in Review

AXQ Capital sold out of Phibro Animal Health (PAHC) in Q2 2025, closing a stake of 10,645 shares — an estimated $227K sold.

AXQ Capital first reported a position in PAHC in Q1 2025 and held it in 1 quarter. The position peaked at $227K in Q1 2025. 194 funds tracked by Wall St. Rank hold PAHC as of Q2 2025.

AXQ Capital reported no remaining Phibro Animal Health position as of Q2 2025 after selling out during the quarter.
AXQ Capital sold 10,645 Phibro Animal Health shares in Q2 2025, an estimated $227K.
AXQ Capital first reported a position in Phibro Animal Health in Q1 2025 and held it in 1 quarter.
AXQ Capital's Phibro Animal Health position peaked at $227K in Q1 2025.
194 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2025.

Based on AXQ Capital's 13F filing for Q2 2025, filed 12 Aug 2025.